Market Overview:
The global in vitro diagnostics systems market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing prevalence of chronic diseases, rising demand for early diagnosis and treatment, and technological advancements in in vitro diagnostics systems. Based on type, the global in vitro diagnostics systems market is segmented into blood tests, urine tests, and other tests. The blood tests segment is further divided into molecular diagnostics, clinical chemistry, diabetes and glucose testing, immunochemistry, hematology (blood cell analysis), coagulation (clotting) testing; while the urine test segment is further classified into urinalysis (urine analysis), pregnancy testing kits & home-use ovulation kits. In terms of application area; molecular diagnostics accounted for the largest share of the global in vitro diagnostic system market in 2017 owing to its ability detect minute changes at a DNA or RNA level that are associated with various diseases such as cancer.
Product Definition:
In vitro diagnostics (IVD) systems are used to detect and identify diseases and other medical conditions in a sample of tissue, blood, or other bodily fluids taken from a patient. IVD systems can be used to diagnose problems such as cancer, infections, and heart disease. They are also used to monitor the progress of treatment for these conditions. The importance of IVD systems lies in their ability to provide early diagnosis and treatment for serious medical conditions.
Blood Tests:
Blood tests are used for the diagnosis of diseases and disorders. These tests also help in monitoring certain parameters such as blood sugar levels, electrolyte imbalance, and other body fluids such as proteins, enzymes & hormones etc. The global blood tests market is expected to witness significant growth over the forecast period owing to factors such as rising prevalence of chronic diseases coupled with increasing geriatric population base which is more prone to these disorders.
Urine Tests:
Urine tests are used in IVD systems to detect the presence of specific chemical substances in the urine. These tests are considered as one of the most important and basic diagnostic tools for identifying diseases related to urinary tract. Urine test is also known as a urinalysis or urine analysis.
The global urine tests market was valued at over USD 9 billion in 2014.
Application Insights:
The molecular diagnostics segment dominated the global in vitro diagnostic systems market in 2017. This is owing to factors such as an increase in demand for rapid, accurate, and sensitive tests for the detection of genetic abnormalities. Furthermore, an increase in prevalence of chronic diseases such as cancer and diabetes coupled with a rise in spending on healthcare by governments across the world is expected to create huge opportunities over the forecast period.
Clinical chemistry is estimated to be one of the fastest-growing segments during the forecast period due to factors such as increasing number of patients suffering from acute illnesses requiring intensive care along with rising government funding for research & development activities pertaining to clinical Chemistry testing procedures. Furthermore, a rise in demand due to increased incidence rate of diseases coupled with R&D investments by various companies are also expected fuel segment growth over next few years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and increasing healthcare expenditure in this region. Moreover, favorable reimbursement policies are also expected to drive regional growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels and improving healthcare infrastructure coupled with growing demand for medical testing services in emerging countries such as China and India. In addition, a rise in investments by public & private entities for development of innovative diagnostic products is also expected favorably impact regional market growth during the same period (2018-2030). Furthermore, government initiatives encouraging R&D activities within developing economies are further anticipated boost industry expansion over next eight years (2018-2030).
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. In addition, there is a growing awareness about the early diagnosis and treatment of chronic diseases among patients and healthcare professionals alike. This is driving the demand for in vitro diagnostics systems for accurate diagnosis and treatment planning.
- Technological advancements: The in vitro diagnostics market is witnessing rapid technological advancements, with new products being launched regularly to cater to the needs of different customer segments. These advancements are helping to improve accuracy, speed, and efficiency while reducing costs associated with diagnostic procedures. This is resulting in increased adoption rates for in vitro diagnostics systems across all end-user segments.
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vitro Diagnostics Systems Market Research Report
By Type
Blood Tests, Urine Tests
By Application
Molecular Diagnostics, Clinical Chemistry, Diabetes and Glucose Testing, Immunochemistry, Hematology, Others
By Companies
SCIEX, Abbott, BioMérieux, Roche, Beckman Coulter, Bio-Rad, Ortho Clinical Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global In Vitro Diagnostics Systems Market Report Segments:
The global In Vitro Diagnostics Systems market is segmented on the basis of:
Types
Blood Tests, Urine Tests
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Molecular Diagnostics, Clinical Chemistry, Diabetes and Glucose Testing, Immunochemistry, Hematology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SCIEX
- Abbott
- BioMérieux
- Roche
- Beckman Coulter
- Bio-Rad
- Ortho Clinical Diagnostics
Highlights of The In Vitro Diagnostics Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Tests
- Urine Tests
- By Application:
- Molecular Diagnostics
- Clinical Chemistry
- Diabetes and Glucose Testing
- Immunochemistry
- Hematology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vitro Diagnostics Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In Vitro Diagnostics Systems is a global company that provides innovative diagnostic solutions for the pharmaceutical, biotechnology and medical device industries. The company's products include flow cytometry, immunoassays and other laboratory tests. In Vitro Diagnostics Systems' products are used to help identify potential problems with drugs, devices and other medical products before they cause serious health problems.
Some of the major players in the in vitro diagnostics systems market are SCIEX, Abbott, BioM©rieux, Roche, Beckman Coulter, Bio-Rad, Ortho Clinical Diagnostics.
The in vitro diagnostics systems market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In Vitro Diagnostics Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In Vitro Diagnostics Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In Vitro Diagnostics Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In Vitro Diagnostics Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In Vitro Diagnostics Systems Market Size & Forecast, 2020-2028
4.5.1 In Vitro Diagnostics Systems Market Size and Y-o-Y Growth
4.5.2 In Vitro Diagnostics Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Blood Tests
5.2.2 Urine Tests
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Molecular Diagnostics
6.2.2 Clinical Chemistry
6.2.3 Diabetes and Glucose Testing
6.2.4 Immunochemistry
6.2.5 Hematology
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In Vitro Diagnostics Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In Vitro Diagnostics Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Blood Tests
9.6.2 Urine Tests
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Molecular Diagnostics
9.10.2 Clinical Chemistry
9.10.3 Diabetes and Glucose Testing
9.10.4 Immunochemistry
9.10.5 Hematology
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Blood Tests
10.6.2 Urine Tests
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Molecular Diagnostics
10.10.2 Clinical Chemistry
10.10.3 Diabetes and Glucose Testing
10.10.4 Immunochemistry
10.10.5 Hematology
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Blood Tests
11.6.2 Urine Tests
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Molecular Diagnostics
11.10.2 Clinical Chemistry
11.10.3 Diabetes and Glucose Testing
11.10.4 Immunochemistry
11.10.5 Hematology
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Blood Tests
12.6.2 Urine Tests
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Molecular Diagnostics
12.10.2 Clinical Chemistry
12.10.3 Diabetes and Glucose Testing
12.10.4 Immunochemistry
12.10.5 Hematology
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Blood Tests
13.6.2 Urine Tests
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Molecular Diagnostics
13.10.2 Clinical Chemistry
13.10.3 Diabetes and Glucose Testing
13.10.4 Immunochemistry
13.10.5 Hematology
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In Vitro Diagnostics Systems Market: Competitive Dashboard
14.2 Global In Vitro Diagnostics Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SCIEX
14.3.2 Abbott
14.3.3 BioMérieux
14.3.4 Roche
14.3.5 Beckman Coulter
14.3.6 Bio-Rad
14.3.7 Ortho Clinical Diagnostics
